Characterization of chronic overlapping pain conditions in patients with chronic migraine: A CHOIR study

Meredith J. Barad,John A. Sturgeon,Juliette Hong,Anuj K. Aggarwal,Sean C. Mackey
DOI: https://doi.org/10.1111/head.14129
2021-06-01
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Chronic overlapping pain conditions (COPCs) represent a co-aggregation of widespread pain disorders. We characterized differences in physical and psychosocial functioning in patients with chronic migraine (CM) and those with CM and COPCs.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Patients with CM and COPCs have been identified as a distinct subgroup of patients with CM, and these patients may be vulnerable to greater symptom severity and burden.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Data were extracted from Collaborative Health Outcomes Information Registry (an open-source learning health-care system), completed at the patients' first visit at a large tertiary care pain management center and electronic medical records. In 1601 patients with CM, the number of non-cephalic areas of pain endorsed on a body map was used to examine the differences in pain, physical and psychosocial function, adverse life experience, and health-care utilization.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Patients endorsing more body map regions reported significantly worse symptoms and function across all domains. Scored on a <i>t</i>-score metric (mean = 50, SD = 10), endorsement of one additional body map region corresponded with a 0.69-point increase in pain interference (95% CI = 0.55, 0.82; <i>p</i> &lt; 0.001; Cohen's <i>f</i> = 0.328), 1.15-point increase in fatigue (95% CI = 0.97, 1.32; <i>p</i> &lt; 0.001; Cohen's <i>f</i> = 0.432), and 1.21-point decrease in physical function (95% CI = −1.39, −1.03; <i>p</i> &lt; 0.001; Cohen's <i>f</i> = 0.560). Patients with more widespread pain reported approximately 5% more physician visits (95% CI = 0.03, 0.07; <i>p</i> &lt; 0.001), and patients reporting adverse life events prior to age 17 endorsed 22% more body map regions (95% CI = 0.11, 0.32; <i>p</i> &lt; 0.001). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Patients with CM and other overlapping pain conditions as noted on the body map report significantly worse pain-related physical function, psychosocial functioning, increased health-care utilization, and greater association with adverse life experiences, compared with those with localized CM. This study provides further evidence that patients with CM and co-occurring pain conditions are a distinct subgroup of CM and can be easily identified through patient-reported outcome measures.</p></section>
clinical neurology
What problem does this paper attempt to address?